berotralstat sold brand name orladeyo medication used prevent attacks hereditary angioedema hae people aged twelve years common side effects include abdominal pain vomiting diarrhea back pain berotralstat approved medical use united states december european union april berotralstat approved based evidence one clinical trial trial participants hereditary trial conducted sites united states european union trial investigators evaluated participants years hereditary angioedema eight weeks determine number attacks trial enrolled participants least two attacks eightweek participants assigned receive one two doses berotralstat placebo every day neither participants investigators knew treatment given trial participants could use medications treatment drug article relating blood blood forming organs stub help wikipedia expanding ithttpsenwikipediaorgwikiberotralstat